Table 1.

Profiles of each patient and any adverse events observed

LevelCaseAge/genderDiagnosisCancer lesionPSPre-TxAdverse events
I00166/FRecurrence after complete surgical resection, adenocarcinomaLung, pleura0ST, CTHot flash, headache, GOT, GPT, total bilirubin elevation
I00278/MRecurrence after complete surgical resection, squamous cell carcinomaLung, SCLN; mediastinal LN1RTNone
I00378/MRecurrence after complete surgical resection, squamous cell carcinomaLung1CTArrhythmia, LDH elevation
II00466/MRecurrence after complete surgical resection, adenocarcinomaLung0CTFacial paralysis
II00555/MRecurrence after complete surgical resection, adenocarcinomaLung, pleura0CTHeadache, general fatigue
II00661/FRecurrence after complete surgical resectionLung, brain0STFever, γ-GTP elevation
  • Abbreviations: SCLN, supraclavicular lymph node; LN, lymph node; PS; performance status; pre-Tx, treatment after recurrence and before clinical trial; ST, surgical treatment of the recurrent lesions; RT, radiation therapy; CT, chemotherapy; GOT, glutamic-oxalacetic transaminase; GPT, glutamic-pyruvic transaminase; LDH, lactate dehydrogenase.